
API and parent drug
Uridine
CAS 58-96-8 · C9H12N2O6 · 7 related records
01API identity and structure

| API / medicine name | Uridine |
|---|---|
| CAS RN | 58-96-8 |
| PubChem CID | 6029 |
| Molecular formula | C9H12N2O6 |
| Molecular weight | 244.20 g/mol |
| IUPAC name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
| Defined stereocentres | 4 |
| Unassigned stereocentres | 0 |
| SMILES | C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O |
|---|---|
| InChI | Not listed |
| InChIKey | DRTQHJPVMGBUCF-XVFCMESISA-N |
02Stereochemistry
The published structure contains 4 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.
Published same-connectivity configurations
6 recordsThese records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

![2D structure: 1-[(2R,3R,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione](/structures/pubchem/7059437/no-cas-1-2r-3r-4s-5s-3-4-dihydroxy-5-hydroxymethyl-oxolan-2-yl-pyrimidine-2-4-dione-2d-structure-300.png)
1-[(2R,3R,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
CAS Not listed
DRTQHJPVMGBUCF-MLQRGLMKSA-N
4 defined, 0 unassigned centres
![2D structure: 1-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione](/structures/pubchem/6559159/no-cas-1-2s-3s-4r-5r-3-4-dihydroxy-5-hydroxymethyl-oxolan-2-yl-pyrimidine-2-4-dione-2d-structure-300.png)
1-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
CAS Not listed
DRTQHJPVMGBUCF-YTQLPXDHSA-N
4 defined, 0 unassigned centres

Cytarabine EP Impurity A / Uracil Arabinoside
CAS 3083-77-0
DRTQHJPVMGBUCF-CCXZUQQUSA-N
4 defined, 0 unassigned centres


Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.
03Structural nitrosamine screen
No record-level structural candidate is currently published for this identity.
This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.
04India status for this compound
The result below applies only to this exact compound identity and CAS number.
| NDPS / RCS | NOT FOUND IN REVIEWED ENTRIES | No exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision. |
|---|---|---|
| SCOMET | NOT FOUND IN REVIEWED CAS ENTRIES | CAS 58-96-8 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated. |
- Narcotic Drugs and Psychotropic Substances Act, 1985, ScheduleDepartment of Revenue, Government of India · source version 1985-09-16
- Controlled-substances notifications and amendmentsDepartment of Revenue, Government of India · source version 2026-03-11
- Appendix 3, SCOMET ListDirectorate General of Foreign Trade, Government of India · source version 2024-09-02
06Sources
- S01PubChem compound record, CID 6029
Structure, identifiers and machine-readable properties for the API identity.
- S02NCBI website and molecular data policies
Reuse policy for NCBI molecular data. Vendor descriptions and contributed narrative text are not reproduced.
- S03Lazychem chemical records
Parent-family links use the supplied parent identity.







